Clinical Trials Browser

Phase 1/2 × Interventional × Caspofungin × Clear all

NCT02856178 2018-02-15

SAFEGUARD

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Invasive Pulmonary Aspergillosis